Abstract

Missense mutations in the pore-forming α1-subunits of voltage-gated calcium channels (Cav) have been linked to a range of neurodevelopmental and neurodegenerative disorders such as autism, epilepsy, developmental delay and ataxia. Here we prove the pathogenicity of heterozygous variants in L-type Cav1.3 (CACNA1D) and P/Q-type Cav2.1 (CACNA1A) channels identified in patients with neurological pathologies using the whole-cell patch-clamp technique with heterologously expressed channel complexes. Previously, we demonstrated that pathogenic de novo missense mutations in the Cav1.3 channel gating machinery induce typical gating changes compatible with a gain-of-function phenotype.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.